Ukr.Biochem.J. 2014; Volume 86, Issue 2, Mar-Apr, pp. 129-133

doi: http://dx.doi.org/10.15407/ubj86.02.129

Effect of С(60) fullerene on metabolic and proliferative activity of PKE cell line

11.06.2015   Uncategorized   No comments

I. V. Belochkina1, I. О. Ishchenko1, S. V. Prylutska2, K. I. Bogutska2,
V. V. Cherepanov3, B. P. Sandomirskiy1, Yu. I. Prylutskyy2

1Institute for Problems of Cryobiology and Cryomedicine,
National Academy of Sciences of Ukraine, Kharkiv;
e-mail: bsan38@yahoo.com;
2Taras Shevchenko National University of Kyiv;
e-mail: prylut@ukr.net;
3Institute of Physics, National Academy of Sciences of Ukraine, Kyiv

The effect of С60 fullerene aqueous colloid solution (C60FAS) on activity of redox and proliferative processes in PKE (transplantable cell line of pig kidney embryo) cells has been studied. In particular, it was established that the presence of С60 fullerene (127 μМ) in culturing medium of PKE cells during 48 h did not change their ability to reduce non-toxic АlamarBlue redox indicator and proliferative acti­vity.

Keywords: , , ,

References:

  1. Fullerenes. Principles and Applications. eds.: Langa de la Puente F., Nierengarten J. F. Cambridge: RSC Edition, 2007. 400 p.
  2. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes. Series: Carbon Materials: Chemistry and Physics. F. Cataldo, T. Da Ros (eds.). Netherlands: Springer, 2008; Vol. 1.  408 р.
  3. Prylutska SV,  Kichmarenko YuM,  Bogutska KI,  Prylutskyy YuI. Fullerene C60 and its derivatives as anticancer agents: problems and prospects. Biotechnology.  2012;5(3):9-17.
  4. Johnston HJ, Hutchison GR, Christensen FM, Aschberger K, Stone V. The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. Toxicol Sci. 2010 Apr;114(2):162-82. Review. PubMed, CrossRef
  5. Prylutska SV, Rotko DM, Prylutskiy YuI, Rybalchenko VK. Toxicity of carbon nanostructures in vitro and in vivo systems.  Modern  Probl.  Toxicol. 2012;(3-4):49–57.
  6. Su Y, Xu JY, Shen P, Li J, Wang L, Li Q, Li W, Xu GT, Fan C, Huang Q. Cellular uptake and cytotoxic evaluation of fullerenol in different cell lines. Toxicology. 2010 Mar 10;269(2-3):155-9. PubMed, CrossRef
  7. Rouse JG, Yang J, Barron AR, Monteiro-Riviere NA. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol In Vitro. 2006 Dec;20(8):1313-20. PubMed, CrossRef
  8. Grebinyk SM, Palyvoda KO, Prylutska SV, Grynyuk II, Samoylenko AA, Drobot LB, Matyshevska OP. Photoactivated fullerene C60 induces store-operated Ca2 entry and cytochrome c release in Jurkat cells. Ukr Biokhim Zhurn. 2012 Nov-Dec;84(6):58-63. PubMed
  9. Andreichenko KS, Prylutska SV, Medynska KO, Bogutska KI, Nurishchenko NE, Prylutskyy YI, Ritter U, Scharff P. Effect of fullerene C60 on ATPase activity and superprecipitation of skeletal muscle actomyosin. Ukr Biokhim Zhurn. 2013 Mar-Apr;85(2):20-6. PubMed, CrossRef
  10. Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, Larroque C. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun. 2002 May 31;294(1):116-9. PubMed, CrossRef
  11. Prylutska S, Bilyy R, Overchuk M, Bychko A, Andreichenko K, Stoika R, Rybalchenko V, Prylutskyy Y, Tsierkezos NG, Ritter U. Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane. J Biomed Nanotechnol. 2012 Jun;8(3):522-7. PubMed, CrossRef
  12. Prylutska SV, Burlaka AP, Prylutskyy YI, Ritter U, Scharff P. Pristine C(60) fullerenes inhibit the rate of tumor growth and metastasis. Exp Oncol. 2011 Sep;33(3):162-4. PubMed
  13. Prylutska SV, Burlaka AP, Klymenko PP, Grynyuk II, Prylutskyy YuI, Schütze Ch, Ritter U. Using water-soluble C60 fullerenes in anticancer therapy. Cancer Nanotechnol. 2011;2(1-6): 105-110. CrossRef
  14. Didenko G, Prylutska S, Kichmarenko Y, Potebnya G, Prylutskyy Y, Slobodyanik N, Ritter U, Scharff P. Evaluation of the antitumor immune response to C60 fullerene. Mat.-wiss. u. Werkstofftech. 2013;44(2-3):124-128. CrossRef
  15. Grynyuk II,  Perepelytsina OM,  Prylutska SV,  Garmanchuk LV,  Khranovska NN, Matyshevska OP, Sydorenko MV.  Influence of fullerenes C60 on the survivability of breast cancer cell line MCF-7 during long-term incubation. Biotechnology. 2010;3,(4):75–79.
  16. Scharff P,  Risch K,  Carta-Abelmann L,  Dmytruk IM,  Bilyi MM, Golub OA, Khavryuchenko АV,  Buzaneva EV,  Aksenov VL, Avdeev MV ,  Prylutskyy YuI,  Durov SS.  Structure of C-60 fullerene in water: spectroscopic data. Carbon. 2004;42(5–6):1203–1206. CrossRef
  17. Prylutska SV, Matyshevska OP , Grynyuk II,  Prylutskyy YuI, RitterU, Scharff P. Biological effects of C60 fullerenes in vitro and in a model system. Mol Cryst Liq Cryst. 2007; 468(1):265-274. CrossRef
  18. Petrenko YA, Gorokhova NA, Tkachova EN, Petrenko AY. The reduction of Alamar Blue by peripheral blood lymphocytes and isolated mitochondria. Ukr Biokhim Zhurn. 2005 Sep-Oct;77(5):100-5. PubMed
  19. Lakin GF. Biometrics. M.: Vysshaya Shkola, 1990. 352 p.
  20. Bulavin L, Adamenko I ,  Prylutskyy Yu, Durov S,  Graja A,  Bogucki A,  Scharff P. Structure of fullerene C60 in aqueous solution. Phys Chem Chem Phys. 2000;2(8):1627-1629. CrossRef
  21. Prylutskyy YI, Buchelnikov AS, Voronin DP, Kostjukov VV, Ritter U, Parkinson JA, Evstigneev MP. C60 fullerene aggregation in aqueous solution. Phys Chem Chem Phys. 2013 Jun 21;15(23):9351-60. Epub 2013 May 10. PubMed, CrossRef
  22. Prilutski YuI, Durov SS,  Yashchuk VN,  Ogul’chansky TYu, Pogorelov VE,  Astashkin YuA,  Buzaneva EV,  Kirghizov YuD,  Andrievsky GV,  Scharff P. Theoretical predictions and experimental studies of self-organization C60 nanoparticles in water solution and on the support. Eur Phys J D. 1999;9(1-4):341-343. CrossRef
  23. Prylutskyy YuI,  Durov SS, Bulavin LA,  Adamenko II,  Moroz KO,  Geru II,  Dihor IN,  Scharff P,  Eklund PC,  Grigorian L. Structure and thermophysical properties of fullerene C60 aqueous solution. Inter J Thermophys. 2001;22(3):943-956. CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.